Endocrinology, Vol 124, 1684-1688, Copyright © 1989 by Endocrine Society

ARTICLES

Thermogenic effects of the antiglucocorticoid RU-486 in the rat: involvement of corticotropin-releasing factor and sympathetic activation of brown adipose tissue

AJ Hardwick, EA Linton and NJ Rothwell
Department of Physiological Sciences, University of Manchester, United Kingdom.

Acute injection (sc) of the antiglucocorticoid RU-486 (5-10 mg/kg) stimulated oxygen consumption (VO2) and brown adipose tissue (BAT) activity (mitochondrial GDP binding) in the rat. A peak effect was seen 60-80 min after injection. The rise in VO2 was prevented by prior injection of the beta-adrenergic antagonist propranolol, and the effect on BAT was abolished by surgical denervation of the sympathetic supply to the tissue. Central injection (cerebroventricular) of a much lower dose (3-8 micrograms/kg) of RU-486 also stimulated VO2, and this effect was inhibited by a CRF receptor antagonist [alpha-helical CRF-(9-41)]. Peripheral injection of RU-486 also elicited acute thermogenic responses in older (greater than 12 months) rats and in genetically obese (Zucker) rats. In lean animals, daily injection of RU-486 inhibited weight gain and stimulated BAT without affecting food intake. The thermogenic effects of RU-486 appear to be due to central stimulation of sympathetic outflow and may involve CRF release. The data support previous studies on the effects of adrenalectomy and CRF on thermogenesis in the rat.

This article has been cited by other articles:

				C. Doyon, P. Samson, J. Lalonde, and D. Richard Effects of the CRF1 receptor antagonist SSR125543 on energy balance and food deprivation-induced neuronal activation in obese Zucker rats J. Endocrinol., April 1, 2007; 193(1): 11 - 19. [Abstract] [Full Text] [PDF]

				S. L. Moore and J. E. Fewell Mifepristone (RU38486) influences the core temperature response of term pregnant rats to intraperitoneal lipopolysaccharide Exp Physiol, July 1, 2006; 91(4): 741 - 746. [Abstract] [Full Text] [PDF]

				M. Koban, W. W. Le, and G. E. Hoffman Changes in Hypothalamic Corticotropin-Releasing Hormone, Neuropeptide Y, and Proopiomelanocortin Gene Expression during Chronic Rapid Eye Movement Sleep Deprivation of Rats Endocrinology, January 1, 2006; 147(1): 421 - 431. [Abstract] [Full Text] [PDF]

				T. Masaki, G. Yoshimichi, S. Chiba, T. Yasuda, H. Noguchi, T. Kakuma, T. Sakata, and H. Yoshimatsu Corticotropin-Releasing Hormone-Mediated Pathway of Leptin to Regulate Feeding, Adiposity, and Uncoupling Protein Expression in Mice Endocrinology, August 1, 2003; 144(8): 3547 - 3554. [Abstract] [Full Text] [PDF]

				M. J. Bradbury, M. I. McBurnie, D. A. Denton, K.-F. Lee, and W. W. Vale Modulation of Urocortin-Induced Hypophagia and Weight Loss by Corticotropin-Releasing Factor Receptor 1 Deficiency in Mice Endocrinology, August 1, 2000; 141(8): 2715 - 2724. [Abstract] [Full Text] [PDF]